Model for evaluating cost-effectiveness of surveillance testing for SARS-CoV2
Silver, J.
Show abstract
Testing people without symptoms for SARS-CoV-2 followed by isolation of those who test positive could mitigate the covid-19 epidemic pending arrival of an effective vaccine. Key questions for such programs are who should be tested, how often, and when should such testing stop. Answers to these questions depend on test and population characteristics. A cost-effectiveness model that provides answers depending on user-adjustable parameter values is described. Key parameters are the value ascribed to preventing a death and the reproduction number (roughly, rate of spread) at the time surveillance testing is initiated. For current rates of spread, cost-effectiveness usually requires a value per life saved greater than $100,000 and depends critically on the extent and frequency of testing.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Identifying Optimal COVID-19 Testing Strategies for Schools and Businesses: Balancing Testing Frequency, Individual Test Technology, and Cost 94%
- Threshold analyses on rates of testing, transmission, and contact for COVID-19 control in a university setting 94%
- Which COVID policies are most effective? A Bayesian analysis of COVID-19 by jurisdiction 94%
Similar papers in this journal
- Effects of Mitigation and Control Policies in Realistic Epidemic Models Accounting for Household Transmission Dynamics 93%
- Evaluation of Contact-Tracing Policies Against the Spread of SARS-CoV-2 in Austria– An Agent-Based Simulation 93%
- Pricing Treatments Cost-Effectively When They Have Multiple Indications: Not Just a Simple Threshold Analysis 92%
Similar papers in this journal
- Impact of Population Mixing Between a Vaccinated Majority and Unvaccinated Minority on Disease Dynamics: Implications for SARS-CoV-2 94%
- Mathematical modeling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada 90%
- Respiratory syncytial virus vaccination strategies for older Canadian adults: a cost-utility analysis 90%
Similar papers in this journal
- Modelling Disease Mitigation at Mass Gatherings: A Case Study of COVID-19 at the 2022 FIFA World Cup 94%
- Covasim: an agent-based model of COVID-19 dynamics and interventions 94%
- Using Test Positivity and Reported Case Rates to Estimate State-Level COVID-19 Prevalence and Seroprevalence in the United States 94%
Similar papers in this journal
- Model-driven mitigation measures for reopening schools during the COVID-19 pandemic 94%
- Economic evaluation of disease elimination: an extension to the net benefits framework and application to human African trypanosomiasis 94%
- Dynamic Prioritization of COVID-19 Vaccines When Social Distancing is Limited for Essential Workers 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.